About: http://data.cimple.eu/news-article/a7e448c5c0288f49cffecac24a706b712a2f10fb5e66bfe196d6e553

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/a7e448c5c0288f49cffecac24a706b712a2f10fb5e66bfe196d6e553 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	US President Donald Trump will announce on Thursday a deal for 150 million rapid COVID-19 tests as he eyes a return to normal life ahead of November's elections, White House officials told AFP. The purchase from Abbott Laboratories is part of a $750 million deal with the company, a senior administration official said. It comes a day after the Food and Drug Administration granted emergency approval for a rapid test made by the Illinois-based firm that is billed as costing $5 and giving results in 15 minutes. "This is a major development that will help our country to remain open, get Americans back to work and kids back to school," White House communications director Alyssa Farah said. "The Trump Administration is proud to partner with Abbott labs to make this purchase possible to help the American people." CNBC reported Trump will debut the deal in a speech Thursday accepting his party's nomination for a second term on the final night of the Republican National Convention. Abbott did not respond to a request for comment. The United States is home to the world's worst coronavirus outbreak, with more than 180,000 deaths and 5.8 million cases, according to Johns Hopkins University. Trump is up against former vice president Joe Biden in what is expected to be a tough re-election contest in November, with voters weighing the impact from the COVID-19 outbreak that's also caused tens of millions of job losses and a sharp economic downturn. Expanding testing is seen as key to controlling the spread of the coronavirus, and Abbott said on Wednesday the test called BinaxNOW, which is about the size of a credit card, is 97 percent sensitive within the first seven days of symptom onset. It will be coupled with a free app called NAVICA that will let people display their recent testing results upon demand. "BinaxNOW and the NAVICA app give us an affordable, easy-to-use, scalable test, and a complementary digital health tool to help us have a bit more normalcy in our daily lives," Abbott CEO Robert B. Ford said in a statement. cs/hs
schema:headline	Trump to announce deal to buy 150 mn rapid COVID tests
schema:mentions	Digital health White House Communications Director 2020 coronavirus outbreak in Singapore Gerald Ford Credit card 2016 Republican National Convention Agence France-Presse CNBC Robert F. Kennedy Presidency of Donald Trump Chief executive officer Coronavirus disease Joe Biden United States Severe acute respiratory syndrome coronavirus 2 President of the United States Donald Trump Alyssa Farah Abbott Laboratories The Final Night Johns Hopkins Bloomberg School of Public Health Normal Life
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-08-27 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	79 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software